4,9-DIFLUORO-11.BETA.,21-DIHYDROXY-16.ALPHA.,17-(1-METHYLETHYLIDENEDIOXY)PREGNA-1,4-DIENE-3,20-DIONE,
UNII MTT42VGB66
Substance Identification & Data
This profile provides standardized clinical and technical data for 4,9-difluoro-11.beta.,21-dihydroxy-16.alpha.,17-(1-methylethylidenedioxy)pregna-1,4-diene-3,20-dione,, uniquely identified by the FDA Unique Ingredient Identifier (UNII) MTT42VGB66.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number N/A and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C24H30F2O6 RLLFFHJFDIBDBN-BLEYLIQZSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 4,9-difluoro-11.beta.,21-dihydroxy-16.alpha.,17-(1-methylethylidenedioxy)pregna-1,4-diene-3,20-dione,. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.